papaverine hydrochloride
Generic: papaverine hydrochloride
Labeler: oryza pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
papaverine hydrochloride
Generic Name
papaverine hydrochloride
Labeler
oryza pharmaceuticals inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
papaverine hydrochloride 30 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
72516-024
Product ID
72516-024_2b4bd8c6-2b93-d435-e063-6394a90ae742
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
UNAPPROVED DRUG OTHER
Listing Expiration
2026-12-31
Marketing Start
2021-02-01
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72516024
Hyphenated Format
72516-024
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
papaverine hydrochloride (source: ndc)
Generic Name
papaverine hydrochloride (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 30 mg/mL
Packaging
- 10 VIAL in 1 CARTON (72516-024-10) / 2 mL in 1 VIAL
- 25 VIAL in 1 CARTON (72516-024-25) / 2 mL in 1 VIAL
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "2b4bd8c6-2b93-d435-e063-6394a90ae742", "openfda": {"unii": ["23473EC6BQ"], "rxcui": ["1789947"], "spl_set_id": ["5ba6e650-a5b5-4381-a62a-b7a6df73e8e6"], "manufacturer_name": ["Oryza Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 CARTON (72516-024-10) / 2 mL in 1 VIAL", "package_ndc": "72516-024-10", "marketing_start_date": "20210201"}, {"sample": false, "description": "25 VIAL in 1 CARTON (72516-024-25) / 2 mL in 1 VIAL", "package_ndc": "72516-024-25", "marketing_start_date": "20210201"}], "brand_name": "Papaverine Hydrochloride", "product_id": "72516-024_2b4bd8c6-2b93-d435-e063-6394a90ae742", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "72516-024", "generic_name": "Papaverine Hydrochloride", "labeler_name": "Oryza Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Papaverine Hydrochloride", "active_ingredients": [{"name": "PAPAVERINE HYDROCHLORIDE", "strength": "30 mg/mL"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20210201", "listing_expiration_date": "20261231"}